Outset Medical (OM) Depreciation & Amortization (CF) (2019 - 2026)

Outset Medical (OM) has reported Depreciation & Amortization (CF) for 8 consecutive years, with $627000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 45.71% year-over-year to $627000.0 in Q2 2026; TTM through Jun 2026 was $3.3 million, a 36.83% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, down 24.21% from the prior year.
• Depreciation & Amortization (CF) was $627000.0 for Q2 2026 at Outset Medical, down from $795000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.5 million in Q2 2023 and troughed at $627000.0 in Q2 2026.
• A 5-year average of $1.2 million and a median of $1.3 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) climbed 14.35% in 2023 and tumbled 45.71% in 2026, its largest moves.
• Over 5 years, Depreciation & Amortization (CF) stood at $1.3 million in 2022, then increased by 13.95% to $1.4 million in 2023, then retreated by 2.77% to $1.4 million in 2024, then sank by 37.34% to $881000.0 in 2025, then slipped by 28.83% to $627000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $627000.0 (Q2 2026), $795000.0 (Q1 2026), and $881000.0 (Q4 2025), per Business Quant data.